Table 5 Antibiotic therapies
Antibiotic, n (%) | Early responders n = 332 | Later responders n = 253 |
|---|---|---|
Combinations | ||
Penicillin or penicillin + β-lactamase inhibitor + macrolide | 50 (15.1) | 22 (8.7) |
Cephalosporin (except cefuroxime) + macrolide | 33 (9.9) | 48 (19.0) |
Cephalosporin (except cefuroxime) + fluoroquinolone | 25 (7.5) | 34 (13.4) |
Penicillin or penicillin–β-lactamase + fluoroquinolone | 16 (4.8) | 17 (6.7) |
Monotherapies | ||
Amoxicillin–clavulanate | 75 (22.6) | 15 (5.9) |
Amoxicillin | 25 (7.5) | 3 (1.2) |
Ceftriaxone | 25 (7.5) | 16 (6.3) |
Levofloxacin | 22 (6.6) | 16 (6.3) |
Moxifloxacin | 15 (4.5) | 10 (4.0) |
Ampicillin–sulbactam | 5 (1.5) | 3 (1.2) |
Piperacillin–tazobactam | 4 (1.2) | 7 (2.8) |
Azithromycin | 4 (1.2) | 3 (1.2) |
Clarithromycin | 3 (0.9) | 3 (1.2) |
Cefuroxime | 3 (0.9) | 2 (0.8) |
Meropenem | 1 (0.3) | 2 (0.8) |
Ciprofloxacin | 0 | 2 (0.8) |